Capital Observer
A diary of the thought process behind my investment decisions
Over The Top
It looks like a Genzyme deal is happening. I have added to my already monster Gilead position and bought a large position in Amgen Calls. Over the top on large cap biotech.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment